Research suggests that milk thistle and its primary active component, silymarin, may have a beneficial effect on cholesterol and related lipid markers, though the current evidence has notable limitations. The available studies include two randomized controlled trials, a systematic review, and several smaller experimental studies conducted in animals, cell cultures, or computational models — meaning much of the supporting evidence does not yet come from large, well-controlled human trials. The 2017 RCT showed meaningful reductions in total cholesterol, LDL, and triglycerides, but milk thistle was tested as part of a multi-ingredient supplement rather than in isolation, making it difficult to attribute the results to silymarin alone; similarly, a 2010 systematic review of herbal medicines for high cholesterol did not identify milk thistle as a standout intervention in human trials. Studies indicate that silymarin may influence lipid metabolism through several biological pathways, including effects on liver function and enzyme activity, but the strongest findings currently come from animal and laboratory research, and independent human clinical trials specifically isolating milk thistle's effects on cholesterol remain limited.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Feasible feeding strategies for sustainable management of serve heat stress c... | RCT | 2024 | Supports | 72 |
| The efficacy and safety of herbal medicines used in the treatment of hyperlip... | Systematic review | 2010 | Mixed | 67 |
| An in vitro and in vivo study of a 4-herb formula on the management of diet-i... | Other | 2018 | Supports | 62 |
| Biogenic integrated ZnO/Ag nanocomposite: Surface analysis and in vivo practi... | Other | 2020 | Supports | 57 |
| Modelling key ecological factors influencing the distribution and content of ... | Other | 2025 | Neutral | 52 |
| Dual inhibition of carbonic anhydrases VA and VII by silychristin and isosily... | Other | 2025 | Supports | 47 |
| Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin... | RCT | 2017 | Supports | 42 |